Fahrleitner-Pammer, A; Muschitz, C; Resch, H; Wagner, D; Amrein, K; Pilz, S; Tomaschitz, A; Pieber, T; Dimai, HP.
DEVIDE-study: DEnosumab Versus Intravenous ibanDronate - a 24 months respective head to head real life study.
J Bone Miner Res. 2013; Supplement 1(MO0381):-ASBMR; Oct 4th - 7th 2013; Baltimore, USA.
[Poster]
FullText